Scleroderma and modern laboratory diagnostics of the disease
Scleroderma is not just a “skin disease,” as is sometimes thought at first. In fact, it is an autoimmune process that can affect not only the skin, but also the blood vessels, esophagus, lungs, kidneys, heart, and other organs. That is why laboratory diagnostics plays a very important role here: it helps not only to confirm the suspicion, but also to understand what type of course the doctor is dealing with and what complications need to be paid special attention to.
The most important thing to know right away: Scleroderma is not diagnosed with a single test.. There is no “magic test” that alone will put an end to it. The current approach is a combination of clinical symptoms, examination, autoantibody tests, and additional examinations that show whether internal organs are involved.
Why is laboratory diagnostics so important?
In the early stages, scleroderma may not start very loudly. Some people first experience Raynaud's syndrome, swelling or thickening of the fingers, skin changes, heartburn, dry mouth, a feeling of tightness in the skin, joint pain, or unexplained fatigue. Some of these symptoms may appear "blurred," so laboratory tests can either strengthen the suspicion or, conversely, force you to look for another cause.
But even more importantly, autoantibody tests often give the doctor a clue not only about the fact of the disease itself, but also about its possible type, activity, and risks of damage to the lungs, kidneys, or other organs. Therefore, modern laboratory diagnostics of the disease is important not only at the confirmation stage, but also for further monitoring.
What tests are prescribed most often?
The first step in the laboratory part of the diagnosis is usually antinuclear antibodies, or ANA. This test itself is not specific for scleroderma, but it is often positive in systemic autoimmune diseases. If the clinical picture is similar to scleroderma, the doctor will usually move on to more targeted autoantibodies.
The most significant in scleroderma are:
- anticentromeric antibodies;
- anti-Scl-70;
- anti-RNA polymerase III.
Other antibodies may be detected in some patients, depending on symptoms, type of lesion, and suspicion of cross-autoimmune syndromes.
Table: which laboratory indicators are most often used in scleroderma
| Indicator | What information does it provide? | Clinical significance |
|---|---|---|
| ANA (antinuclear factor) | Indicates the presence of autoimmune reactivity | Initial screening, but does not diagnose scleroderma by itself |
| Anticentromeric antibodies (ACA) | More often indicate a limited variant of the disease | Help predict a slower course, but with frequent vascular manifestations |
| Anti-Scl-70 | More often associated with diffuse type | Indicates a higher likelihood of pulmonary fibrosis — requires close respiratory monitoring |
| Anti-RNA polymerase III | Also a marker of diffuse form | Signals an increased risk of renal crisis, so blood pressure and creatinine control are critical |
| Complete blood count | Detects associated changes (anemia, inflammatory changes) | Non-specific, but provides a general background for assessing the condition |
| Creatinine, urea, general urine analysis, blood pressure | Assess the excretory function of the kidneys | Especially important in systemic forms, where the kidneys are one of the targets |
| Creatine phosphokinase (CPK) and other muscle enzymes | Show possible involvement of muscle tissue | Helps identify concomitant myositis, if present |
This table is important for understanding a simple thing: modern laboratory diagnostics of scleroderma include not only autoantibodies, but also basic tests that help assess the general condition and possible organ damage.
What does a positive ANA mean?
Many people are scared at this stage. But a positive ANA does not automatically mean scleroderma. It can also occur in other autoimmune conditions, and sometimes even in people without clinically significant disease. That is why ANA is not a ready diagnosis, but only part of the puzzle.
For a doctor, it is much more important not just that the ANA is positive, but what symptoms accompany it and what specific antibodies are found next.
Why are anticentromeric antibodies important?
Anticentromeric antibodies are most often associated with the limited form of systemic scleroderma. This does not mean that this form is “mild” or does not require attention. It is simply that its clinical profile is often different from the diffuse form. Such antibodies help the doctor to more accurately assess the overall course of the disease and better plan further follow-up.
What does anti-Scl-70 do?
Anti-Scl-70 is one of the most important markers in the topic of systemic scleroderma. It is more often associated with the diffuse form of the disease and a higher risk of interstitial lung damage. That is why this analysis is important not only as a “confirmation”, but also as a guideline for how carefully the lungs should be evaluated at the start.
Why might a doctor prescribe anti-RNA polymerase III?
This marker is especially important when diffuse scleroderma is suspected. It is associated with a higher risk of scleroderma renal crisis. This does not mean that such a crisis will necessarily develop, but that is why the doctor will be especially attentive to blood pressure, kidney function and the general course of the disease.
Why tests do not replace other examinations
One of the main mistakes is to think that if all the key antibodies are already present, then the diagnosis is complete. In fact, it is not. Even with very informative laboratory indicators, the doctor often needs to assess whether there is damage to the lungs, heart, kidneys, or blood vessels.
That is why modern diagnostics of scleroderma often include not only blood tests, but also:
- capillaroscopy;
- assessment of lung function;
- echocardiography;
- in some cases, CT scan of the lungs or other instrumental methods.
That is, the laboratory part is very important, but it does not exist separately from a complete assessment of the body.
When to see a doctor
Don't wait until symptoms become obvious and severe. If they appear:
- Raynaud's syndrome;
- skin thickening or tightness;
- swelling of the fingers;
- ulcers on the fingers;
- persistent heartburn or difficulty swallowing;
- unexplained shortness of breath;
- constant fatigue combined with other symptoms,
It is better not to postpone the consultation. It is at the early stage that modern laboratory diagnostics of the disease can be of the greatest benefit.
What not to do yourself
You should not try to interpret individual antibodies without a doctor. Even very well-known markers do not make sense in isolation from symptoms and the overall clinical picture. You should also not calm down just because “one test was normal” if the symptoms are very similar to a systemic disease. Scleroderma is not a topic where the correct conclusion can be made from one line on a form.
Key takeaways
- Scleroderma is not a local process. This is a systemic disease, so diagnosis cannot be narrowly focused.
- No analysis is definitive. The diagnosis is made based on a combination of symptoms, laboratory and instrumental data.
- Specific antibodies are prognostic markers. They help to understand the type of course (limited or diffuse) and assess the risks to the lungs, kidneys, and heart, but do not determine the patient's fate on their own.
- A laboratory without instrumental methods is incomplete. For a real picture, capillaroscopy, breathing tests, echocardiography, and other examinations are needed.
- Diagnosis starts with a doctor, not the Internet. Independent interpretation of indicators in such a complex autoimmune disease is the path to unwarranted anxiety or, worse, to false peace.
Modern laboratory diagnostics of scleroderma is not a separate tool, but an integral part of a doctor's systemic thinking. It allows not only to confirm assumptions, but also to build a patient's route taking into account individual risks, so as not to miss the threat where it can be predicted.
Director of Medi Lab Plus LLC, a doctor of the highest category. Has over 45 years of practical experience in medicine and laboratory diagnostics. Founder and head of the laboratory since 2007. More details…
